Home Alzheimer’s Disease Retrospective Analysis Using Social Vulnerability Index Highlights At Risk Populations Following Surgery

Retrospective Analysis Using Social Vulnerability Index Highlights At Risk Populations Following Surgery

Following several common oncologic procedures, patients with a high Social Vulnerability Index (SVI) had a higher greater likelihood of having a complication, extended length of stay, or 90-day mortality, according to a retrospective analysis published in the Journal of the American College of Surgeons.1

Using the SVI, a composite metric proposed by the Centers for Disease Control, investigators used 15 variables derived from United States Census tract data to characterize the resiliency of a community when faced by external pressures and stresses. The goal of the study was to determine whether SVI was associated with postoperative outcomes following resection. More specifically, investigators sought to evaluate whether social determinates of health (SDH) as assessed by SVI were associated with achieving a “textbook outcome” (TO), an established composite quality metric, following…

Continue Reading to the Source


Please enter your comment!
Please enter your name here

Most Popular

Third COVID-19 Vaccine Earns Emergency Use Authorization Following Favorable Advisory Committee Meeting

The first single-dose COVID-19 vaccine was granted Emergency Use Authorization (EUA) by the FDA, according to its developer Janssen Pharmaceutical Companies of Johnson &...

Abiraterone Acetate, Apalutamide Likeliest to Improve Survival for Patients with Castration-Sensitive Prostate Cancer

In a comparison of systemic treatments as add-ons to androgen-deprivation therapy (ADT) for patients with metastatic castration-sensitive prostate cancer (mCSPC), abiraterone acetate (Zytiga) and...

Women of Minority Race/Ethnicity, Lower Socioeconomic Status Experience Lower Digital Breast Tomosynthesis Access

A cross-sectional study of digital breast tomosynthesis (DBT) screening published in JAMA Network Open indicated that women of minority race/ethnicity and lower socioeconomic status...

Michael Szarek, PhD, on the Outcomes of a Q-TWiST Analysis From the Phase 3 TIVO-3 Study

An analysis revealed that as a third- or fourth-line treatment for RCC, tivozanib significantly increased Q-TWiST compared with sorafenib, primarily through an increase in...

Recent Comments